Cameron Gray's Insider Trades & SAST Disclosures
Cameron Gray's most recent trade in Cue Biopharma Inc was a trade of 61,111 Warrants done . Disclosure was reported to the exchange on June 14, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cameron Gray.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Cameron Gray | Director | 14 Jun 2022 | 61,111 | 0 | - | - | Warrants | ||
| Cue Biopharma Inc | Cameron Gray | Director | 14 Jun 2022 | 61,111 | 738,611 (3%) | 0% | 2.7 | 165,000 | Common Stock | |
| Cue Biopharma Inc | Cameron Gray | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.20 per share. | 14 Jun 2022 | 51,562 | 687,049 (2%) | 0% | 3.2 | 164,998 | Common Stock |
| Cue Biopharma Inc | Cameron Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Cameron Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Cameron Gray | Director | Purchase of securities on an exchange or from another person at price $ 15.30 per share. | 29 Sep 2020 | 5,000 | 677,500 (2%) | 0% | 15.3 | 76,500 | Common Stock |
| Cue Biopharma Inc | Cameron Gray | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 29 Sep 2020 | 5,000 | 672,500 (2%) | 0% | 15 | 75,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges